Quality of life assessment in patients with moderate to severe allergic rhinitis treated with montelukast and/or intranasal steroids: a randomised, double-blind, placebo-controlled study

No abstract is available for this paper.

• Publication year

  2014

• Venue

  The Journal of Laryngology & Otology

• Publication date

  2014-03-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1017/S002221511400036XPMID 24618303
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• [Allergic rhinitis and its impact on asthma].

  2010cited by this paper
• Efficacy and safety of montelukast in adults with asthma and allergic rhinitis.

  2006cited by this paper
• Randomized, double-blind, placebo-controlled study of montelukast for treating perennial allergic rhinitis.

  2005cited by this paper
• Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis.

  2003cited by this paper
• Executive Summary of the Workshop Report
7–10 December 1999, Geneva, Switzerland

  2002cited by this paper
• Allergic rhinitis and its impact on asthma. In collaboration with the World Health Organization. Executive summary of the workshop report. 7-10 December 1999, Geneva, Switzerland.

  2002cited by this paper
• Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall.

  2002cited by this paper
• Relationship between allergic rhinitis, disturbed cognitive functions and psychological well‐being

  2002cited by this paper
• Clinical safety and tolerability of montelukast, a leukotriene receptor antagonist, in controlled clinical trials in patients aged ≥ 6 years

  2001cited by this paper
• Allergic rhinitis and its impact on asthma.

  2001cited by this paper
• Cognitive, social, and economic costs of allergic rhinitis.

  2000cited by this paper
• The cost of productivity losses associated with allergic rhinitis.

  2000cited by this paper
• Increasing prevalence of specific IgE to aeroallergens in an adult population: two cross-sectional surveys 8 years apart: the Copenhagen Allergy Study.

  2000cited by this paper
• Development and validation of the Mini Rhinoconjunctivitis Quality of Life Questionnaire

  2000cited by this paper
• The role of leukotriene D4 in allergic rhinitis.

  1988cited by this paper

• Efficacy and Safety of Combined Pharmacotherapies in Moderate‐to‐Severe Allergic Rhinitis: A Network Meta‐Analysis

  2025cites this paper
• [Modern approaches to rational combination pharmacotherapy of allergic rhinitis].

  2024cites this paper
• A Synopsis of Guidance for Allergic Rhinitis Diagnosis and Management From ICAR 2023.

  2023cites this paper
• Montelukast in paediatric asthma and allergic rhinitis: a systematic review and meta-analysis

  2023cites this paper
• International consensus statement on allergy and rhinology: Allergic rhinitis – 2023

  2023cites this paper
• Combined medical therapy in the treatment of allergic rhinitis: Systematic review and meta‐analyses

  2022cites this paper
• Changes in olfaction & quality of life following standard medical therapy in patients with intermittent & persistent allergic rhinitis

  2022cites this paper
• Turkish Guideline for Diagnosis and Treatment of Allergic Rhinitis (ART)

  2021cites this paper
• International consensus statement on allergy and rhinology: rhinosinusitis 2021

  2020cites this paper
• Leukotriene receptor antagonist addition to intranasal steroid: systematic review and meta-analysis.

  2020influential citation
• Efficacy of Montelukast in Allergic Rhinitis Treatment: A Systematic Review and Meta-Analysis

  2020cites this paper
• House Dust Mite-Induced Allergic Rhinitis: Is Prevention an Option?

  2019cites this paper
• Individualized treatment for allergic rhinitis based on key nasal clinical manifestations combined with histamine and leukotriene D4 levels

  2018cites this paper
• Burden of allergic respiratory disease: a systematic review

  2016cites this paper
• Aalborg Universitet Burden of allergic respiratory disease a systematic review

  2016cites this paper
• Corticosteroids for Allergic Rhinitis

  2016cites this paper
• The efficacy and safety of H1-antihistamine versus Montelukast for allergic rhinitis: A systematic review and meta-analysis.

  2016cites this paper